Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A TYRRELL

Showing results (101-110 of 138) with videos related to

Pageof 14
Sort By:
Antimicrobial Agents and Chemotherapy|May 1, 1985
Studies on 44 081 R.P., a new antirhinovirus compound, in cell cultures and in volunteersA Zerial, G H Werner, R J Phillpotts, et al.
British Medical Journal|May 14, 1977
Undescribed toxin in pseudomembranous colitisH E Larson, J V Parry, A B Price, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1983
Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteersP G Higgins, R J Phillpotts, G M Scott, et al.
Lancet (London, England)|May 3, 1986
A major role for viruses in acute childhood encephalopathyC R Kennedy, K Chrzanowska, R O Robinson, et al.
Journal of Interferon Research|January 1, 1983
Comparative intranasal pharmacokinetics of interferon using two spray systemsH W Davies, G M Scott, J A Robinson, et al.
Archives of Virology|January 1, 1987
Failure of intranasally administered 4', 6-dichloroflavan to protect against rhinovirus infection in manW Al-Nakib, J Willman, P G Higgins, et al.
Clinical Allergy|March 1, 1988
Influence of atopy on the clinical manifestations of coronavirus infection in adult volunteersK A Callow, D A Tyrrell, R J Shaw, et al.
Acta Oto-Laryngologica|March 1, 1989
Changes in human nasal mucosa during experimental coronavirus common coldsM Bende, I Barrow, J Heptonstall, et al.
Antiviral Research|November 1, 1988
Failure to demonstrate synergy between interferon-alpha and a synthetic antiviral, enviroxime, in rhinovirus infections in volunteersP G Higgins, G I Barrow, W al-Nakib, et al.
Psychological Medicine|August 1, 1983
An investigation of the effects of intracerebral injection in the marmoset of cytopathic cerebrospinal fluid from patients with schizophrenia or neurological diseaseH F Baker, R M Ridley, T J Crow, et al.
Pageof 14

Showing results (101-110 of 138) with videos related to

Sort By:
Pageof 14
Antimicrobial Agents and Chemotherapy|May 1, 1985
Studies on 44 081 R.P., a new antirhinovirus compound, in cell cultures and in volunteersA Zerial, G H Werner, R J Phillpotts, et al.
British Medical Journal|May 14, 1977
Undescribed toxin in pseudomembranous colitisH E Larson, J V Parry, A B Price, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1983
Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteersP G Higgins, R J Phillpotts, G M Scott, et al.
Lancet (London, England)|May 3, 1986
A major role for viruses in acute childhood encephalopathyC R Kennedy, K Chrzanowska, R O Robinson, et al.
Journal of Interferon Research|January 1, 1983
Comparative intranasal pharmacokinetics of interferon using two spray systemsH W Davies, G M Scott, J A Robinson, et al.
Archives of Virology|January 1, 1987
Failure of intranasally administered 4', 6-dichloroflavan to protect against rhinovirus infection in manW Al-Nakib, J Willman, P G Higgins, et al.
Clinical Allergy|March 1, 1988
Influence of atopy on the clinical manifestations of coronavirus infection in adult volunteersK A Callow, D A Tyrrell, R J Shaw, et al.
Acta Oto-Laryngologica|March 1, 1989
Changes in human nasal mucosa during experimental coronavirus common coldsM Bende, I Barrow, J Heptonstall, et al.
Antiviral Research|November 1, 1988
Failure to demonstrate synergy between interferon-alpha and a synthetic antiviral, enviroxime, in rhinovirus infections in volunteersP G Higgins, G I Barrow, W al-Nakib, et al.
Psychological Medicine|August 1, 1983
An investigation of the effects of intracerebral injection in the marmoset of cytopathic cerebrospinal fluid from patients with schizophrenia or neurological diseaseH F Baker, R M Ridley, T J Crow, et al.
Pageof 14